Key facts
- arcomedLab’s last known valuation is $7.0M (Oct 2023).
- It has raised $3.6M; the latest was Later Stage VC ($2.5M) in Jan 2025.
- Notable investors include AIR Capital, Cambridge Innovation Center, Rosenberg, The Ganesha Lab.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for arcomedLab
- ·The full record, as it builds
Funding rounds
No funding rounds for arcomedLab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About arcomedLab
Manufacturer of craniofacial implants intended to provide health technologies to patients. The company specializes in customized synthetic bone implant solutions and controlled drug release systems, enabling users with personalized medicine.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2018
- Employees
- 17
- Website
- arcomedlab.com/
- Ownership
- Privately Held (backing)
arcomedLab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in arcomedLab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on arcomedLab in its N-PORT filings yet. We sweep new filings monthly.